EGFR and neoplasm: Thanks to its high binding affinity to the EGFR receptor, several EGFR-binding ligands, such as EGF or its functional fragments, were proposed as decorating molecules for anti-tumour drug-loaded nanoparticle surfaces to achieve tumour cell-specific delivery [6].